Extra Layer Of Support

NCT03532997 | Completed

• 1 other identifier: Pro00089227
• Study Type: interventional
• Target: 151
• Locations: 1 country
• Sites: 1

Brief Summary

The investigators aim to introduce patients with advanced cancer to supportive care resources, including specialty palliative care, through a novel app called "ELOS" (stands for "extra layer of support) in a prospective cohort study. The investigators will compare participant acceptance of this new electronic tool to industry standards and follow ultimate referrals to outpatient palliative care compared to historical, matched controls.

Conditions

Advanced Cancer; Palliative Care

Outcome Measures

Primary Outcomes (3)

• Usability as measured by the System Usability Scale

  The participant's scores for each question are converted to a new number, added together and then multiplied by 2.5 to convert the original scores of 0-40 to 0-100. Though the scores are 0-100, these are not percentages and should be considered only in terms of their percentile ranking.

  Up to one hour

• Validity as measured by the symptom assessment module

  Up to one hour

• Change in Palliative Care referral

  Baseline

Study Arms (1)

Intervention

EXPERIMENTAL

The investigators aim to introduce patients with advanced cancer to supportive care resources, including specialty palliative care, through a novel app called "ELOS" (stands for "extra layer of support) in a prospective cohort study. The investigators will compare participant acceptance of this new electronic tool to industry standards and follow ultimate referrals to outpatient palliative care compared to historical, matched controls.

Other: ELOS

Interventions

ELOS OTHER

The investigators aim to introduce patients with advanced cancer to supportive care resources, including specialty palliative care, through a novel web-based application called "ELOS" (stands for "extra layer of support) in a prospective cohort study.

Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age \>18
• capacity to give consent
• has received a diagnosis of Stage IV solid tumor malignancy or Stage III pancreas or lung cancer within the 8 weeks prior to consent
• ability to speak and understand English
• has access to a computer and the internet

You may not qualify if:

• Not Age 18 or older
• Does not have capacity to give consent
• Has not received a diagnosis of Stage IV solid tumor malignancy or Stage III pancreas or lung cancer within the 8 weeks prior to consent
• Does not have the ability to speak and understand English
• Does not have access to a computer and the internet

Sponsors & Collaborators

• Duke University: lead
• University of North Carolina, Chapel Hill: collaborator

Study Sites (1)

Duke University Medical Center - Cancer Prevention, Detection and Control

Durham, North Carolina, 27710, United States

Location

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: SUPPORTIVE CARE
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 10, 2018
• First Posted: May 22, 2018
• Study Start: October 1, 2018
• Primary Completion: January 7, 2020
• Study Completion: January 7, 2020
• Last Updated: February 26, 2020

Record last verified: 2020-02

Locations

US (1)